Target prediction analysis indicated four major miR-222 mRNA targets—ARF4, DCAF12, CDKN1B, MYLIP. Downregulation of ARF4 in thyroid cancer results in inefficiency to accumulate radioiodine due to disrupted trafficking of sodium iodide symporter to the plasma membrane [54]. Here, CDKN1B is linked to thyroid cancer.